However, the same group later reported that trastuzumab suppresses the mammary tumor growth and metastasis more efficiently in transgenic mice expressing the exon-16-deleted isoform of human HER2 compared to transgenic mice expressing wild-type human HER2 [113]. Here, ERBB2 is linked to breast cancer.